Neurology
JAMA Network Series: Medical Specialties and the COVID-19 Pandemic
24 Sep, 2020 | 09:45h | UTCEditorial: The COVID-19 Pandemic and the JAMA Network
See articles:
- Cardiology and COVID-19
- Dermatology and COVID-19
- Internal Medicine and COVID-19
- Nephrology and COVID-19
- Neurology and COVID-19
- Oncology and COVID-19
- Ophthalmology and COVID-19
- Otolaryngology–Head and Neck Surgery and COVID-19
- Pediatrics and COVID-19
- Psychiatry and COVID-19
- Surgery and COVID-19
- JAMA Network Open and COVID-19
- JAMA Health Forum and COVID-19
Concise review: Management of acute ischemic stroke
22 Sep, 2020 | 09:26h | UTCManagement of Acute Ischemic Stroke – Critical Care Medicine
A case of probable Parkinson’s disease after SARS-CoV-2 infection
17 Sep, 2020 | 09:40h | UTCA case of probable Parkinson’s disease after SARS-CoV-2 infection – The Lancet Neurology
Commentary on Twitter
Parkinson's disease diagnosed after #SARSCoV2 in a 45 year-old-man https://t.co/SPLKDm1A2U @TheLancetNeuro
This has been reported with many other viruses but appears to be the 1st case with covid, very extensive workup pic.twitter.com/AtQfQXxjtm— Eric Topol (@EricTopol) September 17, 2020
How COVID-19 can damage the brain
17 Sep, 2020 | 09:36h | UTCHow COVID-19 can damage the brain – Nature
Commentary on Twitter
How COVID-19 can damage the brain https://t.co/uQUS5y9AXU 125 people in the United Kingdom with COVID-19 who had neurological or psychiatric effects. 62% had strokes and haemorrhages, and 31% had altered mental states, such as confusion or prolonged unconsciousness.
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
Multisystem effects of COVID-19: A concise review for practitioners
16 Sep, 2020 | 09:14h | UTCMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
Systematic review: Prediction of poor neurological outcome in comatose survivors of cardiac arrest
15 Sep, 2020 | 08:40h | UTCEditorial: ERC‑ESICM guidelines for prognostication after cardiac arrest: time for an update
Commentary on Twitter
Poor neuro-outcome in comatose survivors of CA ->
clinical exam, biomarkers, EEG, neuroimaging reliable predictors within 1st week from ROSC; low/0% FPR but most low sensitivity & risk of bias/confounders: no certainty, multimodal approach prudent #FOAMres https://t.co/GjQNoT1L49 pic.twitter.com/WUZofIslZx— Intensive Care Medicine (@yourICM) September 11, 2020
International consensus recommendations on the diagnostic work-up for malformations of cortical development
8 Sep, 2020 | 00:58h | UTC
Systematic review: Endovascular therapy versus medical treatment for symptomatic intracranial artery stenosis
2 Sep, 2020 | 09:30h | UTC
Factors associated with risk of recurrent transient global amnesia
1 Sep, 2020 | 05:53h | UTCFactors Associated With Risk of Recurrent Transient Global Amnesia – JAMA Neurology (free for a limited period)
#ESCCongress – [Abstract Only] Randomized trial: Low-dose edoxaban in very elderly patients with atrial fibrillation
31 Aug, 2020 | 01:32h | UTCCommentaries: Edoxaban Low-Dose for Elder Care Atrial Fibrillation – ELDERCARE-AF – American College of Cardiology AND ELDERCARE-AF: Edoxaban Superior to Placebo in Preventing Stroke, Systemic Embolism in Elderly Japanese AFib Patients – American College of Cardiology
Commentary on Twitter
Elderly patients with AF who were not candidates for standard doses of oral anticoagulants because of a high risk of bleeding were assigned to receive 15 mg of edoxaban or placebo once daily. Edoxaban was superior to placebo in preventing stroke or systemic embolism. #ESCCongress
— NEJM (@NEJM) August 30, 2020
Delirium and adverse outcomes in hospitalized patients with COVID‐19
28 Aug, 2020 | 08:46h | UTC
Lifting the mask on neurological manifestations of COVID-19
26 Aug, 2020 | 04:07h | UTCLifting the mask on neurological manifestations of COVID-19 – Nature Reviews Neurology
Neuroradiologic manifestations of COVID-19: What the emergency radiologist needs to know
24 Aug, 2020 | 00:32h | UTC
Systematic review: Multiple vs. fewer antiplatelet agents for preventing early recurrence after ischemic stroke or transient ischemic attack
21 Aug, 2020 | 02:25h | UTC
Clinical update: Polymyalgia rheumatica and giant cell arteritis
21 Aug, 2020 | 02:20h | UTCPolymyalgia Rheumatica and Giant Cell Arteritis – JAMA
Cognitive impairment evaluation and management
21 Aug, 2020 | 02:17h | UTCCognitive Impairment Evaluation and Management – Medical Clinics of North America
Review: Effects of COVID-19 on the nervous system
20 Aug, 2020 | 09:39h | UTCEffects of COVID-19 on the nervous system – Cell
Study: 75% of Patients with dementia using psychotropic and opioid medications not made for the disease
19 Aug, 2020 | 09:27h | UTCPrevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US – JAMA (free for a limited period)
Commentaries: These Drugs Carry Risks and May Not Help, But Many Dementia Patients Get Them Anyway – Michigan Medicine AND 3 in 4 Elders with Dementia Fill Prescriptions for Psychotropics or Opioids – NEJM Journal Watch
Commentary from the author (Thread – click for more)
https://twitter.com/dtmaust/status/1295759727754977281
Pseudotumor cerebri syndrome associated with MIS-C/Covid-19: a case report
13 Aug, 2020 | 00:06h | UTCPseudotumor cerebri syndrome associated with MIS-C: a case report – The Lancet
Commentary on Twitter
First report of pseudotumor cerebri, a potentially vision-threatening condition, in a 14-year-old-girl w/ #COVID19 and MIS-C.
Bilateral papilledema, ⬆️intracranial pressure, disc hemorrhages, eye palsyhttps://t.co/xCGuXm9JVf @TheLancet @LanaVerkuil @PennMedicine @ChildrensPhila pic.twitter.com/anrGqdNXjN— Eric Topol (@EricTopol) August 11, 2020
Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder
13 Aug, 2020 | 00:14h | UTC
Pictorial essay: Neurological emergencies associated with COVID-19: stroke and beyond
13 Aug, 2020 | 00:07h | UTCNeurological emergencies associated with COVID-19: stroke and beyond – Emergency Radiology
Case reports: Myasthenia Gravis associated with SARS-CoV-2 infection
11 Aug, 2020 | 10:28h | UTCMyasthenia Gravis Associated With SARS-CoV-2 Infection – Annals of Internal Medicine
Commentary on Twitter
First report of myasthenia gravis, an autoimmune neurologic disorder, from #COVID19 in 3 patients, days after infection symptoms began @AnnalsofIM https://t.co/AL5cSzW4sZ
This wasn't on the #SARSCoV2 neuro listhttps://t.co/jXfFtQK49I @TheLancetNeuro pic.twitter.com/OKCiybGvmW— Eric Topol (@EricTopol) August 10, 2020
[Abstract Only] Randomized trial: Prevention of benign paroxysmal positional vertigo with Vit D supplementation
10 Aug, 2020 | 01:49h | UTCCommentary: Fewer Vertigo Recurrences with Vitamin D, Calcium – Physician’s Weekly
[Abstract Only] Randomized trial: Ofatumumab vs. Teriflunomide in multiple sclerosis
6 Aug, 2020 | 02:43h | UTCOfatumumab versus Teriflunomide in Multiple Sclerosis – New England Journal of Medicine
Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors
4 Aug, 2020 | 03:16h | UTCCommentary: Survivors of Covid-19 show increased rate of psychiatric disorders, study finds – The Guardian